(2021). Prednisone/rituximab: COVID-19: case report. Reactions Weekly.
Chicago Style aipamena"Prednisone/rituximab: COVID-19: Case Report." Reactions Weekly 2021.
MLA aipamena"Prednisone/rituximab: COVID-19: Case Report." Reactions Weekly 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.